Literature DB >> 21764783

Minimizing and communicating radiation risk in pediatric nuclear medicine.

Frederic H Fahey1, S Ted Treves, S James Adelstein.   

Abstract

The value of pediatric nuclear medicine is well established. Pediatric patients are referred to nuclear medicine from nearly all pediatric specialties including urology, oncology, cardiology, gastroenterology, and orthopedics. Radiation exposure is associated with a potential, small, risk of inducing cancer in the patient later in life and is higher in younger patients. Recently, there has been enhanced interest in exposure to radiation from medical imaging. Thus, it is incumbent on practitioners of pediatric nuclear medicine to have an understanding of dosimetry and radiation risk to communicate effectively with their patients and their families. This article reviews radiation dosimetry for radiopharmaceuticals and also CT given the recent proliferation of PET/CT and SPECT/CT. It also describes the scientific basis for radiation risk estimation in the context of pediatric nuclear medicine. Approaches for effective communication of risk to patients' families are discussed. Lastly, radiation dose reduction in pediatric nuclear medicine is explicated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764783     DOI: 10.2967/jnumed.109.069609

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  33 in total

1.  Doctor, is a CT scan safe for my child?

Authors:  M J Goske
Journal:  Br J Radiol       Date:  2013-12-19       Impact factor: 3.039

2.  New developed DR detector performs radiographs of hand, pelvic and premature chest anatomies at a lower radiation dose and/or a higher image quality.

Authors:  Helle Precht; Anders Tingberg; Dag Waaler; Claus Bjørn Outzen
Journal:  J Digit Imaging       Date:  2014-02       Impact factor: 4.056

3.  Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT.

Authors:  Yu-Mo Zhao; Ying-He Li; Tao Chen; Wei-Guang Zhang; Lin-Hao Wang; Jiatai Feng; Chenwei Li; Xu Zhang; Wei Fan; Ying-Ying Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-18       Impact factor: 9.236

4.  Paediatric urological investigations--dose comparison between urology-related and CT irradiation.

Authors:  Mark Page; Cosmin Florescu; Lilian Johnstone; Daniel Habteslassie; Michael Ditchfield
Journal:  Pediatr Radiol       Date:  2013-02-05

Review 5.  Scintigraphic features of duplex kidneys on DMSA renal cortical scans.

Authors:  Neha Kwatra; Eglal Shalaby-Rana; Massoud Majd
Journal:  Pediatr Radiol       Date:  2013-02-06

6.  Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials.

Authors:  Sasan Partovi; Andres A Kohan; Lisa Zipp; Peter Faulhaber; Christos Kosmas; Pablo R Ros; Mark R Robbin
Journal:  Int J Clin Exp Med       Date:  2014-03-15

7.  Reducing the small-heart effect in pediatric gated myocardial perfusion single-photon emission computed tomography.

Authors:  Hiroto Yoneyama; Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Masahisa Onoguchi; Seigo Kinuya; Lars Edenbrandt
Journal:  J Nucl Cardiol       Date:  2016-05-19       Impact factor: 5.952

Review 8.  SPECT/CT in pediatric patient management.

Authors:  Helen R Nadel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-20       Impact factor: 9.236

9.  Gonad dose assessment in paediatric kidney nuclear medicine test using Monte Carlo simulation.

Authors:  Dong-Yeon Lee; Yong-Uk Kye; Hyo-Jin Kim; Jeung-Kee Kim; Yeong-Rok Kang
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

10.  Beyond current guidelines: reduction in minimum administered radiopharmaceutical activity with preserved diagnostic image quality in pediatric hepatobiliary scintigraphy.

Authors:  Frederic Fahey; Katherine Zukotynski; David Zurakowski; Robert Markelewicz; Anthony Falone; Marie Vitello; Xinhua Cao; Frederick Grant; Laura Drubach; A Hans Vija; Manojeet Bhattacharya; Xinhong Ding; Zvi Bar-Sever; Michael Gelfand; S Ted Treves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-06       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.